Xos, Inc. (XOS) 8-K Summary: 2026 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held virtually on June 23, 2026. The meeting addressed six proposals, including director elections, auditor ratification, equity plan amendments, and executive compensation matters. As of the record date (April 24, 2026), the company had 12,056,211 shares of common stock outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Stockholders representing 52.57% of outstanding shares participated in the meeting. All six proposals were approved:
- Director Elections: Three Class II directors (George N. Mattson, Giordano Sordoni, Alice Yake) were elected to serve until the 2029 Annual Meeting.
- Auditor Ratification: Grant Thornton LLP was ratified as the independent auditor for fiscal year 2026.
- Equity Plan Amendment: Stockholders approved an increase of 3,740,000 shares to the 2021 Equity Incentive Plan.
- Executive Compensation: The fiscal year 2025 compensation for named executive officers was approved on a non-binding advisory basis.
- Compensation Vote Frequency: Stockholders advised that future advisory votes on executive compensation should occur every three years.
- Convertible Note Issuance: Stockholders approved the potential issuance of 20% or more of outstanding common stock at prices potentially below the Nasdaq Minimum Price to holders of certain Convertible Promissory Notes, including any associated change of control.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, or management commentary regarding future financial performance. A material risk identified is the potential dilution and change of control resulting from the approved issuance of shares to Convertible Promissory Note holders at prices below the Nasdaq Minimum Price.
Investor Verification Checklist
- Verify the terms and conversion pricing of the Convertible Promissory Notes referenced in Proposal 6.
- Review the definitive proxy statement (Schedule 14A filed May 4, 2026) for detailed biographies of the newly elected directors.
- Monitor the impact of the 3,740,000 share increase to the Equity Incentive Plan on future dilution.
- Confirm the specific conditions under which the "change of control" provision in Proposal 6 would be triggered.